DERMAZENE Trademark

Trademark Overview

On Monday, August 27, 2018, a trademark application was filed for DERMAZENE with the United States Patent and Trademark Office. The USPTO has given the DERMAZENE trademark a serial number of 88094134. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Monday, September 7, 2020. This trademark is owned by Legacy United, LLC. The DERMAZENE trademark is filed in the Pharmaceutical Products category with the following description:

topical pharmaceutical preparations for the treatment of dermatological diseases, disorders and conditions; pharmaceutical preparations for use in dermatology
dermazene

General Information

Serial Number88094134
Word MarkDERMAZENE
Filing DateMonday, August 27, 2018
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateMonday, September 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicestopical pharmaceutical preparations for the treatment of dermatological diseases, disorders and conditions; pharmaceutical preparations for use in dermatology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLegacy United, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilimington, DE 19801

Trademark Events

Event DateEvent Description
Thursday, September 10, 2020ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Monday, September 7, 2020ABANDONMENT - AFTER EX PARTE APPEAL
Monday, September 7, 2020EXPARTE APPEAL TERMINATED
Monday, June 22, 2020EX PARTE APPEAL-REFUSAL AFFIRMED
Tuesday, March 17, 2020NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Tuesday, March 17, 2020EXAMINERS STATEMENT E-MAILED
Tuesday, March 17, 2020EXAMINERS STATEMENT - COMPLETED
Tuesday, January 28, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, December 30, 2019EX PARTE APPEAL-INSTITUTED
Monday, December 30, 2019EXPARTE APPEAL RECEIVED AT TTAB
Sunday, June 30, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, June 30, 2019FINAL REFUSAL E-MAILED
Sunday, June 30, 2019FINAL REFUSAL WRITTEN
Wednesday, June 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 12, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 12, 2018NON-FINAL ACTION WRITTEN
Tuesday, December 11, 2018ASSIGNED TO EXAMINER
Thursday, September 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 30, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

dermazene pharmaceutical preparations conditions dermatology disorders dermatological treatment topical diseases